Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
Human Tumor Necrosis Factor Alpha Antibody Glucocorticoid Conjugates
Abstract: The present disclosure provides human tumor necrosis factor alpha antibody glucocorticoid receptor agonist conjugates and methods of using the conjugates for the treatment of autoimmune and inflammatory diseases.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
10 December 2024
Publication Number
2/2025
Publication Type
INA
Invention Field
BIOTECHNOLOGY
Status
Email
Parent Application
Applicants
ELI LILLY AND COMPANY
LILLY CORPORATE CENTER
Indianapolis, Indiana 46285
Inventors
1. CHAO, Grace
c/o ELI LILLY AND COMPANY
P.O. Box 6288
Indianapolis, Indiana 46206-6288
2. CLAYTON, Joshua R.
c/o ELI LILLY AND COMPANY
P.O. Box 6288
Indianapolis, Indiana 46206-6288
3. CRAMPTON, Jordan Scott
c/o ELI LILLY AND COMPANY
P.O. Box 6288
Indianapolis, Indiana 46206-6288
4. FENG, Yiqing
c/o ELI LILLY AND COMPANY
P.O. Box 6288
Indianapolis, Indiana 46206-6288
5. LEUNG, Donmienne Doen Mun
c/o ELI LILLY AND COMPANY
P.O. Box 6288
Indianapolis, Indiana 46206-6288
6. NA, Songqing
c/o ELI LILLY AND COMPANY
P.O. Box 6288
Indianapolis, Indiana 46206-6288
7. NEWBURN, Kristen Paige
c/o ELI LILLY AND COMPANY
P.O. Box 6288
Indianapolis, Indiana 46206-6288
8. POTTER, Scott Charles
c/o ELI LILLY AND COMPANY
P.O. Box 6288
Indianapolis, Indiana 46206-6288
9. RAMAMURTHY, Bharathi
c/o ELI LILLY AND COMPANY
P.O. Box 6288
Indianapolis, Indiana 46206-6288
10. STOKELL, David John
c/o ELI LILLY AND COMPANY
P.O. Box 6288
Indianapolis, Indiana 46206-6288
11. WURST, Jacqueline M.
c/o ELI LILLY AND COMPANY
P.O. Box 6288
Indianapolis, Indiana 46206-6288
12. XU, Jianghuai
c/o ELI LILLY AND COMPANY
P.O. Box 6288
Indianapolis, Indiana 46206-6288
Specification
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 202417097242-STATEMENT OF UNDERTAKING (FORM 3) [10-12-2024(online)].pdf | 2024-12-10 |
| 3 | 202417097242-Sequence Listing in PDF [10-12-2024(online)].pdf | 2024-12-10 |
| 4 | 202417097242-REQUEST FOR EXAMINATION (FORM-18) [10-12-2024(online)].pdf | 2024-12-10 |
| 5 | 202417097242-POWER OF AUTHORITY [10-12-2024(online)].pdf | 2024-12-10 |
| 6 | 202417097242-FORM-26 [10-12-2024(online)].pdf | 2024-12-10 |
| 7 | 202417097242-FORM 18 [10-12-2024(online)].pdf | 2024-12-10 |
| 8 | 202417097242-FORM 1 [10-12-2024(online)].pdf | 2024-12-10 |
| 9 | 202417097242-DRAWINGS [10-12-2024(online)].pdf | 2024-12-10 |
| 10 | 202417097242-DECLARATION OF INVENTORSHIP (FORM 5) [10-12-2024(online)].pdf | 2024-12-10 |
| 11 | 202417097242-COMPLETE SPECIFICATION [10-12-2024(online)].pdf | 2024-12-10 |
| 12 | 202417097242-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [10-12-2024(online)].pdf | 2024-12-10 |
| 13 | 202417097242-FORM 3 [20-01-2025(online)].pdf | 2025-01-20 |
| 14 | 202417097242-Proof of Right [03-06-2025(online)].pdf | 2025-06-03 |